Fibrosis with excessive amounts of type I collagen is a hallmark of many solid tumours, and fibrosis is a promising target in cancer therapy, but tools for its non-invasive quantification are missing. Here we used magnetic resonance imaging with a gadolinium-based probe targeted to type I collagen (EP-3533) to image and quantify fibrosis in pancreatic ductal adenocarcinoma. An orthotopic syngeneic mouse model resulted in tumours with 2.3-fold higher collagen level compared to healthy pancreas. Animals were scanned at 4.7 T before, during and up to 60 min after i.v. injection of EP-3533, or of its non-binding isomer EP-3612. Ex-vivo quantification of gadolinium showed significantly higher uptake of EP-3533 compared to EP-3612 in tumours, but not in surrounding tissue (blood, muscle). Uptake of EP-3533 visualized in T1-weighted MRI correlated well with spatial distribution of collagen determined by second harmonic generation imaging. Differences in the tumour pharmacokinetic profiles of EP-3533 and EP-3612 were utilized to distinguish specific binding to tumour collagen from non-specific uptake. A model-free pharmacokinetic measurement based on area under the curve was identified as a robust imaging biomarker of fibrosis. Collagen-targeted molecular MRI with EP-3533 represents a new tool for non-invasive visualization and quantification of fibrosis in tumour tissue.

A A Martinos Center for Biomedical Imaging Department of Radiology Massachusetts General Hospital and Harvard Medical School 149 Thirteenth St Suite 2301 Charlestown MA 02129 USA

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo nam 2 16610 Prague 6 Czech Republic

See more in PubMed

Hynes RO. The Extracellular Matrix: Not Just Pretty Fibrils. Science. 2009;326:1216–1219. doi: 10.1126/science.1176009. PubMed DOI PMC

Lu P, Weaver VM, Werb Z. The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol. 2012;196:395–406. doi: 10.1083/jcb.201102147. PubMed DOI PMC

Neesse A, et al. Stromal biology and therapy in pancreatic cancer. Gut. 2011;60:861–868. doi: 10.1136/gut.2010.226092. PubMed DOI

Levental KR, et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell. 2009;139:891–906. doi: 10.1016/j.cell.2009.10.027. PubMed DOI PMC

Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr. Opin. Cell Biol. 2010;22:697–706. doi: 10.1016/j.ceb.2010.08.015. PubMed DOI PMC

Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Model. Mech. 2011;4:165–178. doi: 10.1242/dmm.004077. PubMed DOI PMC

Provenzano PP, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6 doi: 10.1186/1741-7015-6-11. PubMed DOI PMC

Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat. Rev. Cancer. 2009;9:108–122. doi: 10.1038/nrc2544. PubMed DOI PMC

Provenzano PP, et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4 doi: 10.1186/1741-7015-4-38. PubMed DOI PMC

Han, W. et al. Oriented collagen fibers direct tumor cell intravasation. Proc. Natl. Acad. Sci. 201610347, doi:10.1073/pnas.1610347113 (2016). PubMed PMC

Brown E, et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat. Med. 2003;9:796–800. doi: 10.1038/nm879. PubMed DOI

Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010;7:653–664. doi: 10.1038/nrclinonc.2010.139. PubMed DOI PMC

Miao L, Lin CM, Huang L. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. J. Controlled Release. 2015;219:192–204. doi: 10.1016/j.jconrel.2015.08.017. PubMed DOI PMC

Olive KP, et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer . Science. 2009;324:1457–1461. doi: 10.1126/science.1171362. PubMed DOI PMC

Banerjee S, et al. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2016;22:415–425. doi: 10.1158/1078-0432.CCR-15-1155. PubMed DOI PMC

Beatty GL, et al. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans. Science. 2011;331:1612–1616. doi: 10.1126/science.1198443. PubMed DOI PMC

Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc. Natl. Acad. Sci. 2011;108:2909–2914. doi: 10.1073/pnas.1018892108. PubMed DOI PMC

Grossman M, et al. Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix. Cancer Res. 2016;76:4249–4258. doi: 10.1158/0008-5472.CAN-15-2813. PubMed DOI

Khan S, et al. Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer. Cancer Res. 2015;75:2292–2304. doi: 10.1158/0008-5472.CAN-14-2397. PubMed DOI PMC

Chen X, Nadiarynkh O, Plotnikov S, Campagnola PJ. Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure. Nat. Protoc. 2012;7:654–669. doi: 10.1038/nprot.2012.009. PubMed DOI PMC

Polasek M, et al. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J. Hepatol. 2012;57:549–555. doi: 10.1016/j.jhep.2012.04.035. PubMed DOI PMC

Fuchs BC, et al. Molecular MRI of collagen to diagnose and stage liver fibrosis. J. Hepatol. 2013;59:992–998. doi: 10.1016/j.jhep.2013.06.026. PubMed DOI PMC

Farrar CT, et al. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J. Hepatol. 2015;63:689–696. doi: 10.1016/j.jhep.2015.04.029. PubMed DOI PMC

Zhu B, et al. Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology. 2017;65:1015–1025. doi: 10.1002/hep.28930. PubMed DOI PMC

Caravan P, et al. Molecular Magnetic Resonance Imaging of Pulmonary Fibrosis in Mice. Am. J. Respir. Cell Mol. Biol. 2013;49:1120–1126. doi: 10.1165/rcmb.2013-0039OC. PubMed DOI PMC

Helm PA, et al. Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent. Radiology. 2008;247:788–796. doi: 10.1148/radiol.2473070975. PubMed DOI PMC

Hezel AF, et al. TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression. Cancer Res. 2012;72:4840–4845. doi: 10.1158/0008-5472.CAN-12-0634. PubMed DOI PMC

Weissleder R. Molecular Imaging in. Cancer. Science. 2006;312:1168–1171. PubMed

Armstrong T, et al. Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma. Clin. Cancer Res. 2004;10:7427–7437. doi: 10.1158/1078-0432.CCR-03-0825. PubMed DOI

Linder S, Castanos-Velez E, von Rosen A, Biberfeld P. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology. 2001;48:1321–1327. PubMed

Mollenhauer J, Roether I, Kern HF. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas. 1987;2:14–24. doi: 10.1097/00006676-198701000-00003. PubMed DOI

Mahadevan D, Hoff DDV. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 2007;6:1186–1197. doi: 10.1158/1535-7163.MCT-06-0686. PubMed DOI

Feig C, et al. The Pancreas Cancer Microenvironment. Clin. Cancer Res. 2012;18:4266–4276. doi: 10.1158/1078-0432.CCR-11-3114. PubMed DOI PMC

Vong S, Kalluri R. The Role of Stromal Myofibroblast and Extracellular Matrix in Tumor Angiogenesis. Genes Cancer. 2011;2:1139–1145. doi: 10.1177/1947601911423940. PubMed DOI PMC

Oettle H. Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside. Cancer Treat. Rev. 2014;40:1039–1047. doi: 10.1016/j.ctrv.2014.07.003. PubMed DOI

Erkan M, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat. Rev. Gastroenterol. Hepatol. 2012;9:454–467. doi: 10.1038/nrgastro.2012.115. PubMed DOI

Provenzano PP, et al. Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2012;21:418–429. doi: 10.1016/j.ccr.2012.01.007. PubMed DOI PMC

Tofts PS, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging JMRI. 1999;10:223–232. doi: 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S. PubMed DOI

van Bochove GS, et al. Molecular MR Imaging of Collagen in Mouse Atherosclerosis by Using Paramagnetic CNA35 Micelles. Eur. J. Inorg. Chem. 2012;2012:2115–2125. doi: 10.1002/ejic.201200010. DOI

Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat. Rev. Drug Discov. 2014;13:904–927. doi: 10.1038/nrd4390. PubMed DOI

Li W, et al. Magnetization transfer MRI in pancreatic cancer xenograft models. Magn. Reson. Med. 2012;68:1291–1297. doi: 10.1002/mrm.24127. PubMed DOI PMC

Muraoka N, et al. Apparent diffusion coefficient in pancreatic cancer: Characterization and histopathological correlations. J. Magn. Reson. Imaging. 2008;27:1302–1308. doi: 10.1002/jmri.21340. PubMed DOI

Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 2013;19:1410–1422. doi: 10.1038/nm.3389. PubMed DOI

Jacobetz MA, et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2013;62:112–120. doi: 10.1136/gutjnl-2012-302529. PubMed DOI PMC

Stylianopoulos T, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl. Acad. Sci. 2012;109:15101–15108. doi: 10.1073/pnas.1213353109. PubMed DOI PMC

Hingorani, S. R. et al. A phase Ib study of gemcitabine plus PEGPH20 (pegylated recombinant human hyaluronidase) in patients with stage IV previously untreated pancreatic cancer. J. Clin. Oncol. 31 (2013).

Hingorani SR, et al. Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer. Clin. Cancer Res. 2016;22:2848–2854. doi: 10.1158/1078-0432.CCR-15-2010. PubMed DOI PMC

Chauhan VP, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat. Commun. 2013;4 doi: 10.1038/ncomms3516. PubMed DOI PMC

Caravan P, et al. Collagen-Targeted MRI Contrast Agent for Molecular Imaging of Fibrosis. Angew. Chem. Int. Ed. 2007;46:8171–8173. doi: 10.1002/anie.200700700. PubMed DOI

Hutson PR, Crawford ME, Sorkness RL. Liquid chromatographic determination of hydroxyproline in tissue samples. J. Chromatogr. B. 2003;791:427–430. doi: 10.1016/S1570-0232(03)00248-4. PubMed DOI

Preibisch S, Saalfeld S, Tomancak P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics. 2009;25:1463–1465. doi: 10.1093/bioinformatics/btp184. PubMed DOI PMC